Chunghwa Chemical Synthesis & Biotech Co., Ltd. — Investor Relations & Filings
Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB) is a specialized manufacturer of Active Pharmaceutical Ingredients (APIs) with a history dating back to 1964. The company focuses on the research, development, and large-scale production of high-quality APIs, particularly in the therapeutic areas of oncology, antifungal treatments, and immunosuppressants. CCSB offers a broad service portfolio that includes cGMP-compliant contract manufacturing and toll manufacturing. By leveraging advanced chemical synthesis and biotechnology platforms, the company provides tailored solutions to global pharmaceutical partners. CCSB adheres to rigorous international quality standards and environmental, health, and safety protocols, ensuring the reliable supply of critical medicinal components for the global healthcare market.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 公告本公司董事會通過解除經理人競業禁止之限制 | 2026-05-05 | Chinese | |
| 公告本公司董事會通過副總經理任命案 | 2026-05-05 | Chinese | |
| 公告本公司董事會通過115年第一季合併財務報告 | 2026-05-05 | Chinese | |
| 115年04月內部人持股異動(事後) | 2026-05-04 | Chinese | |
| 115年04月董事會成員及持股 | 2026-05-04 | Chinese | |
| 公告本公司115年第一季合併財務報告董事會預計召開日期 為115年5月5日 | 2026-04-27 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 41262616 | 公告本公司董事會通過解除經理人競業禁止之限制 | 2026-05-05 | Chinese | ||
| 41262639 | 公告本公司董事會通過副總經理任命案 | 2026-05-05 | Chinese | ||
| 41263072 | 公告本公司董事會通過115年第一季合併財務報告 | 2026-05-05 | Chinese | ||
| 40861090 | 115年04月內部人持股異動(事後) | 2026-05-04 | Chinese | ||
| 40861081 | 115年04月董事會成員及持股 | 2026-05-04 | Chinese | ||
| 37423826 | 公告本公司115年第一季合併財務報告董事會預計召開日期 為115年5月5日 | 2026-04-27 | Chinese | ||
| 36165932 | 115年年報及股東會資料 — 2026_1762_20260528FE2.pdf | 2026-04-24 | English | ||
| 36165902 | 115年年報及股東會資料 — 2026_1762_20260528FE1.pdf | 2026-04-24 | English | ||
| 36165827 | 115年年報及股東會資料 — 2026_1762_20260528F13.pdf | 2026-04-24 | Chinese | ||
| 36165786 | 115年年報及股東會資料 — 2026_1762_20260528F02.pdf | 2026-04-24 | Chinese | ||
| 36165697 | 115年年報及股東會資料 — 2026_1762_20260528F01.pdf | 2026-04-24 | Chinese | ||
| 33993188 | 115年3月背書保證與資金貸與 | 2026-04-10 | Chinese | ||
| 33991848 | 115年3月營業收入 | 2026-04-10 | Chinese | ||
| 33695685 | 115年03月內部人持股異動(事後) | 2026-04-07 | Chinese | ||
| 33695682 | 115年03月董事會成員及持股 | 2026-04-07 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BioInvent International
Develops novel, first-in-class immuno-modulatory antibodies…
|
BINV | SE | Manufacturing |
|
BIOLIFE SOLUTIONS INC
Manufactures biopreservation media and tools for cell and g…
|
BLFS | US | Manufacturing |
|
BioLineRx Ltd.
A clinical-stage biopharmaceutical company developing thera…
|
BLRX | IL | Manufacturing |
|
BIOMARIN PHARMACEUTICAL INC
A global biotechnology company developing therapies for rar…
|
BMRN | US | Manufacturing |
|
BioMaxima S.A.
Manufacturer and distributor of in-vitro diagnostics for cl…
|
BMX | PL | Manufacturing |
|
Biomea Fusion, Inc.
A clinical-stage biopharma developing oral drugs for diabet…
|
BMEA | US | Manufacturing |
|
BIOME AUSTRALIA LIMITED
Develops and distributes evidence-based probiotics and comp…
|
BIO | AU | Manufacturing |
|
Biome Grow Inc.
Production and distribution of cannabis products focused on…
|
BIO | CA | Manufacturing |
|
BIOMERICA INC
Develops in-vitro diagnostic and therapeutic products for c…
|
BMRA | US | Manufacturing |
|
bioMérieux
A global leader in in vitro diagnostics for clinical and in…
|
BIM | FR | Manufacturing |
Chunghwa Chemical Synthesis & Biotech Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/51917/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=51917 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=51917 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=51917 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 51917}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Chunghwa Chemical Synthesis & Biotech Co., Ltd. (id: 51917)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.